ASPRUZYO SPRINKLE

Product NDC: 47335-625
11-digit product format: 473350625
Labeler code: 47335
Product ID: 47335-625_2cd273e4-313f-3562-e063-6394a90ac135
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Ranolazine
Dosage form: GRANULE
Route: ORAL
Labeler: SUN PHARMACEUTICAL INDUSTRIES, INC.
Application: NDA216018
Marketing category: NDA
Marketing start: 2022-02-28
Substance: RANOLAZINE
Active strength: 1000 mg/1
Pharmacologic classes: Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N216018-001	ASPRUZYO SPRINKLE	RANOLAZINE	500MG	GRANULE, EXTENDED RELEASE / ORAL		RLD	2022-02-28
N216018-002	ASPRUZYO SPRINKLE	RANOLAZINE	1GM	GRANULE, EXTENDED RELEASE / ORAL		RLD	2022-02-28

Orange Book patents#

Current patent rows page 1 of 1 · 4 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Coverage / status	Submission date
N216018-001	11510878	2038-01-24	Drug product	2022-12-01
N216018-002	10898444	2038-01-24	Drug product	2022-03-03
N216018-002	11510878	2038-01-24	Drug product	2022-12-01
N216018-002	12161761	2038-01-24	Drug product	2024-12-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 64 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULE, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULE, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD, RS	2022-02-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD, RS	2022-02-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD, RS	2022-02-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD, RS	2022-02-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD, RS	2022-02-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD, RS	2022-02-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD, RS	2022-02-28	`4b0b4de00fa7…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD, RS	2022-02-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N216018-001	ASPRUZYO SPRINKLE	500MG	GRANULES, EXTENDED RELEASE / ORAL	RLD	2022-02-28	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	N216018-002	ASPRUZYO SPRINKLE	1GM	GRANULES, EXTENDED RELEASE / ORAL	RLD, RS	2022-02-28	`1c564ffb4f44…`

Observed Orange Book patent history#

Patent history page 1 of 3 · 89 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N216018-002	12161761	2038-01-24	Drug product	2024-12-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216018-002	12161761	2038-01-24	Drug product	2024-12-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216018-002	12161761	2038-01-24	Drug product	2024-12-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N216018-002	12161761	2038-01-24	Drug product	2024-12-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N216018-002	12161761	2038-01-24	Drug product	2024-12-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N216018-002	12161761	2038-01-24	Drug product	2024-12-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N216018-002	12161761	2038-01-24	Drug product	2024-12-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N216018-001	11510878	2038-01-24	Drug product	2022-12-01	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N216018-002	10898444	2038-01-24	Drug product	2022-03-03	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N216018-002	11510878	2038-01-24	Drug product	2022-12-01	`d06236e962d9…`

Additional Listing Data#

Finished product: Yes
Brand name base: ASPRUZYO SPRINKLE
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
RANOLAZINE	1000 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
A6IEZ5M406	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2594753	Internal RxNorm lookup
2594759	Internal RxNorm lookup
2594760	Internal RxNorm lookup
2594762	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
dd9f81e4-50da-4551-aed5-559d304df42e	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4367aed1-e488-b72c-d0ec-178a4e054129	Product name	9	20250624
ddc83a74-720a-4975-8550-c4bd979c9094	Product name	1	20221212

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
47335-625-11	ASPRUZYO SPRINKLE	1 in 1 PACKET	GRANULE	1	3
47335-625-30	ASPRUZYO SPRINKLE	30 in 1 CARTON	GRANULE	30	3
47335-625-60	ASPRUZYO SPRINKLE	60 in 1 CARTON	GRANULE	60	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
47335-625-11	EA - Each	47335-625	8e876d3d-3af4-4be1-b455-8d5d1892ead8	1	2022-08-04
47335-625-60	EA - Each	47335-625	45c66337-5ebd-4ada-8dd3-3b9b94222aa7	1	2022-07-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
47335-625	ASPRUZYO SPRINKLE (RANOLAZINE) GRANULE [SUN PHARMACEUTICAL INDUSTRIES, INC.]	3	Current NDC, Legacy NDC, 3 package rows	20250130_dd9f81e4-50da-4551-aed5-559d304df42e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ASPRUZYO SPRINKLE	RANOLAZINE	SUN PHARMACEUTICAL INDUSTRIES, INC.	dd9f81e4-50da-4551-aed5-559d304df42e	2025-01-29	Warnings, Adverse reactions	Exact identifier application applno (NDA): 216018 application number: NDA216018 ndc (product): 47335-625

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
A6IEZ5M406	RANOLAZINE	95635-55-5	RANOLAZINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2594759	ASPRUZYO Sprinkle 1000 MG Oral Granules	PSN	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594762	ASPRUZYO Sprinkle 500 MG Oral Granules	PSN	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594753	ranolazine 1000 MG Oral Granules	PSN	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594760	ranolazine 500 MG Oral Granules	PSN	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594759	ranolazine 1000 MG Oral Granules [Aspruzyo]	SBD	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594762	ranolazine 500 MG Oral Granules [Aspruzyo]	SBD	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594753	ranolazine 1000 MG Oral Granules	SCD	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594760	ranolazine 500 MG Oral Granules	SCD	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594759	Aspruzyo 1000 MG Oral Granules	SY	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594762	Aspruzyo 500 MG Oral Granules	SY	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594759	Aspruzyo Sprinkle 1 GM Oral Granules	SY	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594759	Aspruzyo Sprinkle 1000 MG Oral Granules	SY	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594762	Aspruzyo Sprinkle 500 MG Oral Granules	SY	dd9f81e4-50da-4551-aed5-559d304df42e	3
2594753	ranolazine 1 GM Oral Granules	SY	dd9f81e4-50da-4551-aed5-559d304df42e	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
47335-625-11	47335062511	1 GRANULE in 1 PACKET (47335-625-11)	1 granule	2022-02-28	0000-00-00	No	No	Current
47335-625-30	47335062530	30 GRANULE in 1 CARTON (47335-625-30)	30 granule	2022-02-28	0000-00-00	No	No	Current
47335-625-60	47335062560	60 GRANULE in 1 CARTON (47335-625-60)	60 granule	2022-02-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ASPRUZYO SPRINKLE - SUN PHARMACEUTICAL INDUSTRIES, INC. \| Sun Pharmaceutical Industries Limited	SUN PHARMACEUTICAL INDUSTRIES, INC. \| Sun Pharmaceutical Industries Limited	2025-01-29	HUMAN PRESCRIPTION DRUG LABEL	3